AP
Anokhi Patel
About Anokhi Patel
Anokhi Patel has 7 years in corporate governance. Holds Designated Partner and Partner roles. Currently with 8 companies, including Minerva Molecular Solutions Llp and Mcon Global Event Llp. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Minerva Molecular Solutions Llp
AAW-7858
|
Designated Partner | 21 Apr 2021 | 2021 | Active |
|
Mcon Global Event Llp
AAK-1109
|
Partner | 20 Sep 2018 | 2017 | Active |
|
Gic Prime Pet Ct Centre Llp
ABA-9133
|
Designated Partner | 25 Aug 2025 | 2022 | Active |
|
Cloudnext Labs Llp
ACJ-6086
|
Designated Partner | 25 Sep 2024 | 2024 | Active |
|
Curie Theranostics Llp
ACJ-8046
|
Designated Partner | 07 Oct 2024 | 2024 | Active |
|
Prismaa Oncoimaging Llp
ABB-7953
|
Designated Partner | 23 Apr 2024 | 2022 | Active |
|
Cielo Healthscreenings Llp
ACK-1818
|
Designated Partner | 30 Oct 2024 | 2024 | Active |
|
Cielo Life Sciences Llp
ACG-8117
|
Designated Partner | 25 Apr 2024 | 2024 | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anokhi Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anokhi Patel
Anokhi Patel has 7 years in corporate governance. Holds Designated Partner and Partner roles. Currently with 8 companies, including Minerva Molecular Solutions Llp and Mcon Global Event Llp. Engaged in General Business, Healthcare. Contributes to corporate operations.
Anokhi Patel is associated with 8 companies as Designated Partner and Partner.
Anokhi Patel has expertise in General Business, Healthcare.
Anokhi Patel has 7 years in corporate governance.